Back to Search
JAMES EASTHAM, MD
MD
Urology Physician
NPI: 1447236054IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
209364(NY)
CMS Specialties
PrimaryUROLOGY
Education
UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group.
PMID 17544572·Eur Urol·2008
8-other
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
PMID 18423693·J Urol·2008
8-other
Bone health in men receiving androgen deprivation therapy for prostate cancer.
PMID 17161994·J Urol·2007
6-review
Prognostic significance of location of positive margins in radical prostatectomy specimens.
PMID 18068455·Urology·2007
8-other
Does neurovascular bundle preservation at the time of radical prostatectomy improve urinary continence?
PMID 17297498·Nat Clin Pract Urol·2007
8-other
Surgery Insight: optimizing open nerve-sparing radical prostatectomy techniques for improved outcomes.
PMID 17921971·Nat Clin Pract Urol·2007
6-review
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer.
PMID 16474622·Nat Clin Pract Urol·2005
6-review
Active surveillance for prostate cancer with selective delayed definitive therapy.
PMID 15992461·Clin Prostate Cancer·2005
6-review
Multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer.
PMID 14680451·Expert Opin Investig Drugs·2004
6-review
Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.
PMID 12771116·JAMA·2003
8-other
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
PMID 14634399·J Urol·2003
8-other
Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy.
PMID 12756084·Curr Urol Rep·2003
6-review
Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
PMID 14747042·Urology·2003
3-trial
Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
PMID 11870801·Prostate·2002
4-observational
Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial.
PMID 19594741·BJU Int·2010
3-trial
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
PMID 19636023·J Clin Oncol·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1447236054
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile